Literature DB >> 8547099

Hepatitis C virus infection in multi-transfused children with haematological malignancy.

B Myers1, W Irving, R Hollingsworth, D Readett, J S Lilleyman, G Dolan.   

Abstract

Transmission of hepatitis C virus (HCV) is an important hazard of blood transfusion and may result in chronic liver disease. 98 children from Nottingham and Sheffield with haematological malignancies were studied to determine the prevalence of HCV infection by enzyme immunoassay and RT/PCR techniques. The children had been exposed to up to 184 donors through red cell and platelet transfusion, the majority prior to routine testing for HCV infection in blood donors. Only one sample showed evidence of HCV infection being both ELISA and RT/PCR positive. None of the samples taken since donor screening were positive. This provides reassurance as to the low rate of HCV acquisition in multi-transfused patients in this part of the U.K. compared to other parts of the world.

Entities:  

Mesh:

Year:  1995        PMID: 8547099     DOI: 10.1111/j.1365-2141.1995.tb05327.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Impact of hepatitis B and hepatitis C virus infections in a hematology-oncology unit at a children's hospital in Nicaragua, 1997 to 1999.

Authors:  Kirsten Visoná; Fulgencio Baez; Lizeth Taylor; René Berríos; Bernal León; Carlos Pacheco; Roberto Jirón; Ronald B Luftig; M Mercedes Somarriba
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

2.  Hepatic late adverse effects after antineoplastic treatment for childhood cancer.

Authors:  Renée L Mulder; Dorine Bresters; Malon Van den Hof; Bart Gp Koot; Sharon M Castellino; Yoon Kong K Loke; Piet N Post; Aleida Postma; László P Szőnyi; Gill A Levitt; Edit Bardi; Roderick Skinner; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2019-04-15

3.  The prevalence of molecular and immunologic infective markers of hepatitis viruses in patients with hematological malignancies.

Authors:  Mitra Mirzaee; Ramin Yaghobi; Mani Ramzi; Mahdi Roshan Nia
Journal:  Mol Biol Rep       Date:  2011-05-20       Impact factor: 2.316

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.